8-K
Current Report
Keros Therapeutics, Inc. Filed Acc 0001664710-25-000025
Bylaws or fiscal year change
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading kros-20250305.htm…